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ABSTRACT
OBJECTIVE: The objective of this selective EBM review is to determine whether or not Animal
Assisted Therapy (AAT) using dogs is an effective treatment for positive and negative symptoms
for adult inpatient schizophrenics.
STUDY DESIGN: Systematic review of 3 articles published in English in peer reviewed journals
between 2005-2009
DATA SOURCES: Two randomized controlled trials and one allocation by minimization
controlled trial comparing the effects of AAT using dogs on positive and negative symptoms of
schizophrenia to control groups. All articles were found using PubMed and PROQuest
OUTCOMES MEASURED: Focused questionnaires were given before and after AAT to
analyze the effects on positive and negative symptoms.
RESULTS: Chu et al. and Vilalta-Gil et al. showed improvement following treatment in positive
symptoms. Vilalta-Gil et al. also showed improvement in negative symptoms. Nathans-Barel
showed no improvement in positive or negative symptoms, but marked improvements in hedonic
tone.
CONCLUSIONS: The results of the three studies gave inconclusive evidence for the use of AAT
in the treatment of positive and negative symptoms. Limitations in the study designs, such as size
and lack of follow up, prevent the results from sufficiently identifying a relationship between
AAT and positive and negative symptoms. However, the results encourage further study,
especially when the relatively minimal risk of the intervention is considered.
KEYWORDS: animal assisted, dog therapy, schizophrenia
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INTRODUCTION
Schizophrenia is a complex, common and debilitating psychiatric disorder that is
characterized by two types of symptoms, positive and negative. Positive symptoms are
characterized by a disconnect from reality, such as hallucinations, delusions and deranged
thoughts. Negative symptoms are characterized by disrupted emotions and behaviors such as flat
affect, anhedonia and lack of communication. Schizophrenia has varying forms and degrees of
severity but is often incapacitating, with more than half of individuals experiencing significant
impairment in functioning throughout adulthood.7 It is the most common diagnosis amongst
institutionalized individuals3, with 1/3 of individuals meeting the criteria for a diagnosis.4
Schizophrenia affects 24 million people worldwide, with a prevalence of 7 per 1,000 and
incidence of 3 in every 10,000 due to its chronicity.4
Treatment and management costs are quite substantial due to the need for long term
institutionalization and complex multidimensional therapies, with an estimated total cost of
$62.7 billion (2002) in the US5, and 1.5-3% of the total national health care expenditures
worldwide.6 These large costs make it prudent to search for cost effective treatment methods that
work towards reducing symptomatology associated with the condition and allow them to
function at a higher level, thus easing financial, family and institutional burden associated with
treating institutionalized schizophrenics.
The effects of schizophrenia can be widespread and require extensive care and clinical
interventions. Standard pharmacological treatments using atypical antipsychotics (e.g.
aripiprazol, clozapine) and typical antipsychotics (e.g. chlorpromazine, haloperidol) have been
shown to improve positive symptoms, but are less efficacious with the treatment of negative
symptoms. This is of clinical importance because negative symptoms have been shown to be
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better predictors of long term disability than positive symptoms.3 Alternative approaches such as
Animal Assisted Therapy (AAT) have been shown to improve social functioning and thus aid in
the long term management and autonomy of schizophrenics.1
Many aspects of schizophrenia are not well understood and are a source of continuing
research. The exact etiology of schizophrenia is unknown and is likely without a unifying source;
however research shows several different factors associated with the condition. There is evidence
to support genetic inheritance as playing a role in development, but it is likely that multiple
genes acting in concert are the cause and thus not easily used in predicting prevalence amongst
families. Several genes have been linked with schizophrenia but each account for only a small
proportion of cases.7 Structural abnormalities, such as enlarged lateral ventricles, and reduction
in volume of the hippocampus, temporal and frontal lobes have been shown in effected
individuals. Disruptions in several neurotransmitters, especially dopamine, play a role in the
development of the disease and are important targets for pharmacologic therapy.7 Environmental
stressors, such as; poor family support, physical and emotional neglect and abuse have all been
shown to precede initial onset of the disease process in children, as well as aggravate individuals
with established disease. These stressful events trigger the hypothalamic-pituitary-adrenal (HPA)
axis and cause chronically high levels of cortisol, which can lead to alterations of
neurotransmitter activity and reductions of hippocampal volume.7
Antipsychotic medications that lower dopaminergic activity diminish the severity and
prevalence of psychotic symptoms, especially positive symptoms, but have varying degrees of
motor side effects depending upon the specific agent that is used, with the newer atypicals
having less harmful side effect profiles than the typical antipsychotics.7 Several psychosocial
treatment methods currently exist that aim to improve interpersonal interactions, autonomy, and
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reduce the prevalence of psychotic episodes. Cognitive behavior therapy, family therapy and
stress management techniques have all shown promise as adjunctive therapies to pharmacologic
treatments, though the wide variety in presentations of patients requires various treatment
options.7
Animal Assisted Therapy (AAT) has been shown to have several positive effects such as
helping to improve socialization and communication while decreasing anger, depression, and
anxiety in psychiatric patients.8 AAT also comes with very minimal risk, especially when
compared to the large side effect profiles of the antipsychotic medications that are currently
available. Fear of the animal, allergy, and underlying asthma conditions are among the limited
number of factors that would hinder the use of this therapy.8 This paper evaluates three studies
comparing the effects of regimented exposure to trained therapy dogs to control groups using
clinical questionnaires to evaluate AAT's efficacy on positive and negative symptoms of
institutionalized schizophrenics when used as an adjunctive therapy.
OBJECTIVE
The objective of this systematic review is to determine whether or not animal assisted
therapy using dogs is an effective treatment for positive and negative symptoms for adult
inpatient schizophrenics.
METHODS
The population chosen was adult (>18 y/o) inpatients with clinically diagnosed
schizophrenia. Interventions all involved the use of trained dogs for animal assisted therapy with
variation amongst the studies regarding the specific methods used for AAT. Comparison groups
looked at other institutionalized schizophrenics who were not receiving AAT. All studies used
clinical questionnaires to study the effects of AAT on positive and negative symptoms of
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schizophrenia. The questionnaires and specific symptoms being studied varied between the three
papers. Two randomized controlled trials and one allocation by minimization-controlled trial
were used.
All articles were published in English in peer reviewed journals. Articles were found by
the author in PubMed and PROQuest using the keywords “schizophrenia” AND “animal
assisted” OR “dog therapy”. Articles were selected based on relevance and that the outcomes of
the studies mattered to patients (POEMs). Inclusion criteria were controlled studies using patient
>18 y/o who were also institutionalized schizophrenics. Excluded from the review were studies
looking at children <18y/o, outpatient schizophrenics and the use of animals other than dogs. The
statistics used in the studies all used p-values.
OUTCOMES MEASURED
Chu et al. looked at positive symptoms and negative symptoms (all assessed using an
unnamed self-survey).
Nathans-Barel et al. studied hedonic tone (Snaith-Hamilton Pleasure Scale (SHAPS))
negative symptoms (Schedule for the Assessment of Negative Symptoms (SANS)) and positive
symptoms (Positive And Negative Syndrome Scale (PANSS)).
Villalta-Gil et al. studied positive symptoms and negative symptoms (PANSS)
RESULTS
Three studies compared the use of AAT with dogs on clinically diagnosed
institutionalized schizophrenics who were 18 or older. The studies by Chu et al. and Vilalta-Gil
et al. were both single blind randomized controlled trials and the Nathans-Barel et al. study was
an allocation by minimization controlled trial. No intervention related negative effects or adverse
reactions were reported in any of the 3 studies.
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Table 1: Demographics and Characteristics of Included Studies
Study

Type

# pts

Chu1
(2009)

RCT

30

Nathans2
(2005)

Allocation by 20
minimizationcontrolled
trial

VillaltaGil3
(2009)

RCT

21

Age
Inclusion criteria
(years)
<60
<60, ability to
speak, read and
write mandarin
Chinese,
diagnosis of
schizophrenia for
>10yrs, score >39
on the schedule
for the
assessment of
negative
symptoms, no
cognitive
impairment
19-62 Diagnosed
(mean chronic
39.9)
schizophrenia,
inpatients in longterm ward >2
continuous years,

Exclusion
criteria
Receiving
any other
experimental
treatment
during the
study period

W/D Interventions
3

Weekly 50min
sessions, x8
weeks, of loosely
organized
activities w/ 2
medium sized
trained therapy
dogs

Change in
antipsychotic
medications
<6 months
ago, allergies
to dogs

0

>18

Mental
3
retardation,
neurological
disorders,
adverse
psychological
or physical
reactions to
animals

1hr therapy
sessions, x10
weeks, w/ female
golden retriever.
Patients
interacted with
the dog in a
number of ways
including but not
limited to:
playing,
grooming,
introducing the
dog to new
people, feeding
and walking the
dog
Group therapy
involving a
female Labrador
trained as a
therapy dog. The
sessions had the
patients
performing a
number of
different tasks
involving the
dog directly

>10 years
clinically
diagnosed
schizophrenia,
>18 y/o,
institutionalized
during the
program
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Chu et al. studied 30 patients from a psychiatric institution in Taiwan, all of which were
<60 and >18 years old, could speak, read and write mandarin Chinese, had a diagnosis of
schizophrenia for >10yrs, score >39 on the schedule for the assessment of negative symptoms,
and had no cognitive impairment. Excluded from the study were any patients who were receiving
other experimental treatment during the study period. The 30 patients were randomly split into 2
groups, with one receiving weekly 50 minute sessions with the dog for 8 weeks along with their
regular treatment regimens and the other group receiving only their regularly scheduled
treatment regimens. Sessions consisted of loosely organized activities w/ 2 medium sized trained
therapy dogs. Self-reported questionnaires were given before and after the 8 week trial. Table 2
shows the pre and post treatment scores and the corresponding p-value. Post treatment positive
symptoms were shown to be significantly improved in the treatment group when compared with
the control group using a Mann-Whitney U test (p-value = .005). Negative symptoms were not
significantly improved (p-value = .097)
Table 2: Change in Symptoms Pre and Post AAT Treatment
Treatment Group (mean)
Control Group (mean)
Pre-treatment Post-treatment Pre-treatment Post-treatment p-value
Positive symptoms
14.88
8.46
15.85
16.54
0.005
Negative Symptoms
13.28
10.13
13.78
14.88
0.097

Nathans-Barel et al. studied 20 diagnosed schizophrenics living in a long term care ward
of a hospital for a minimum of two continuous years. Excluded from the study were any
individuals with a change in their antipsychotic medications within the last 6 months and
individuals with an allergy to dogs. The subjects were assigned to the treatment or control group
on a minimization basis in order to reduce age and sex differences, with no reference to clinical
or other factors. Both the treatment and control group received 10 weekly 1 hour sessions with
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the same therapist, with the treatment group participating in activities with a well-trained dog.
The treatment participants were given the choice of several activities to perform with the dog,
including but not limited to: petting, feeding, cleaning, walking and making contact with the dog.
The control group participated in similar activities, but without the dog. Pre and post treatment
SHAPS, PANSS, and SANS questionnaires were administered and compared. Post treatment
scores were compared using an ANCOVA. Positive and negative symptoms failed to show
significant change compared to the control group as seen in table 3 (p-values = 0.82, 0.20
respectively). Hedonic tone was shown to have significant change (p-value = 0.02)
Table 3: Change in Symptoms Pre and Post AAT Treatment

Negative Symptoms
Positive Symptoms
Hedonic Tone

Treatment Group (mean) Control Group (mean)
ANCOVA
Pre
Post
Pre
Post
p-value F
54
48.1
58.1
52.4
0.82
0.05
17.9
16.3
15.8
13.3
0.2
1.79
2.82
3.44
2.89
3.12
0.02
6.3

Villalta-Gil et al. studied 24 inpatients at Saint John of God-Mental Health Services
Hospital in Barcelona Spain. For inclusion, patients had to be over 18 y/o, have diagnosed
schizophrenia for >10 years, and be institutionalized. Excluded were those with mental
retardation, neurological disorders or adverse psychological or physical reactions to animals. Of
those selected, three patients declined to take part in the study prior to it beginning. Following
baseline testing, participants were randomly assigned to the treatment (n=12) or control group
(n=9). Both groups received 25 45 minute sessions, given twice a week of a group based therapy
based on Integrated Psychological Treatment (IPT), with the treatment group receiving a
modified version to allow for the use of the therapy dogs. Using the Wilcoxon signed-rank test,
positive symptoms showed significant improvement following treatment in both the treatment
(p-values = 0.005) and the control (p-value = 0.027) groups, as seen in Table 4. Negative

Davidson, Animal Assisted Therapy and Schizophrenia, 8

symptoms were significantly improved following treatment in the treatment group (p = 0.005)
but not in the control group. There were no significant changes found when comparing the
treatment group to the control group before or after treatment using the Mann Whitney U Test.
Table 4: Changes in Symptoms Pre and Post Treatment
Treatment Group
Pre
Post
Z
p
Negative Symptoms
28.92
19.36
-2.81
Positive Symptoms
20.83
15.64
-2.81

Control Group
Pre
Post
p-value Z
0.005 25.44 16.67
0.005 22.67
17
0.027

-1.89
-2.21

DISCUSSION
This systematic literature review investigated whether or not animal assisted therapy
could improve positive and negative symptoms for inpatient adult schizophrenic patients. The
results obtained in these three studies are inconclusive and requires additional studies to further
examine AAT’s efficacy for schizophrenia. Though this paper looked specifically at positive and
negative symptoms of schizophrenia, the papers looked at several other factors. One observation
that was noted by all researchers was that the patients receiving AAT expressed excitement,
compassion and increased social interactions after starting their program. Such observations,
though not always evident in the statistical analysis, should not be over looked.
All three of the studies that were reviewed share some characteristics that limit their
efficacy. All of the studies were small in size and lacked any follow up after the conclusion of
the study. The outcomes that were measured are inherently subjective and require the completion
of questionnaires to obtain objective data. Schizophrenics are also prone to bouts of psychosis
which could affect the reliability of the questionnaires that were administered. Additionally due
to the nature of the intervention, none of the studies were double blinded.
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In addition to the limitations listed above, the study by Chu et al. used a less structured
method of animal therapy, known as Animal Assisted Activity (AAA) which has a more general
goal of improving patient’s physical health and sense of well-being as opposed to AAT which
has specific aims for each interaction between the patient and the animal. The Nathans-Barel et
al. study was additionally limited by being an allocation by minimization study rather than an
RCT. This makes the results of the study inherently weaker. Finally the Study by Villalta-Gil et
al. had 3 patients drop out (14.3%) before the end of the trial. No mention is made of performing
worst case analysis to account for the loss of these subjects.
AAT with dogs as an adjunctive therapy for schizophrenia has very few drawbacks and
besides those with allergies to the animal, shows very little risk.9 When well trained dogs and
trainers are used, the risk of injury to a patient by the dog is minimal. The initial cost of starting
an AAT program can be large, 9 but is less with dogs than with larger animals like horses.
CONCLUSIONS
Based off of the results highlighted in this review, AAT’s efficacy on positive and
negative symptoms of inpatient schizophrenics is inconclusive. 2 of the 3 studies showed
improvements with positive symptoms, while only 1 showed improvement of negative
symptoms, though hedonic tone was significantly improved in 1 study, and is similar to negative
symptomology. Larger and longer studies must be done to explore AAT’s efficacy in this
population, but early studies show promise. All of the patients studied had diagnosed
schizophrenia, but there were varying degrees of the disease amongst each group member. More
strict regulation of the severity of the subjects’ disease state could potentially more accurately
assess AAT’s efficacy. Additionally using other animals besides dogs could help to expand the
range of possibilities for AAT in this population.
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Schizophrenia is a complex chronic condition that poses significant challenges in its
management. Continued research in the use of adjunctive therapies such as AAT can help
provide additional treatment options in order to improve patient care, lower costs and reduce
unwanted side effects of antipsychotic medications.
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